Home
>
National Drug Code (NDC)
>
TAZTIA
TAZTIA - 62037-699-30 - (Diltiazem Hydrochloride)
Drug Information of TAZTIA
| Product NDC: | 62037-699 |
| Proprietary Name: | TAZTIA |
| Non Proprietary Name: | Diltiazem Hydrochloride |
| Active Ingredient(s): | 300 mg/1 & nbsp; Diltiazem Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TAZTIA
| Product NDC: | 62037-699 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075401 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030410 |
Package Information of TAZTIA
| Package NDC: | 62037-699-30 |
| Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-30) |
NDC Information of TAZTIA
| NDC Code | 62037-699-30 |
| Proprietary Name | TAZTIA |
| Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-30) |
| Product NDC | 62037-699 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Diltiazem Hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20030410 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | DILTIAZEM HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |
